COSCIENS Biopharma Inc. (CSCIF) stock
CSCIFOTCPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
$6.49+0.00 (0.00%)
Close on Oct 19, 2026Market cap $24.10MP/E –Yield –
Earnings
COSCIENS Biopharma's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue, Q1 FY2026
$1.90M
-42.4% on a year earlier
EPS, Q1 FY2026
$3.42
-$2.15 a year earlier
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of COSCIENS Biopharma's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q1 FY2026ended Mar 31, 2026 | May 12, 2026during market hours | $1.90M | -42.4% | $3.42 | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 25, 2026during market hours | $1.80M | – | $0.69 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 12, 2025before the open | $1.50M | -21.1% | $0.57 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 14, 2025during market hours | $2.70M | +17.4% | -$0.75 | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 9, 2025during market hours | $3.30M | – | -$2.15 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 12, 2024before the open | $1.90M | – | -$1.85 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 13, 2024before the open | $2.30M | – | -$0.64 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 15, 2024during market hours | – | – | -$4.74 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 9, 2023before the open | $0 | – | -$0.85 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 9, 2023before the open | – | – | – | Release |
| Q1 FY2023ended Mar 31, 2023 | May 9, 2023during market hours | – | – | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 23, 2023before the open | – | – | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 3, 2022before the open | – | – | – | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 3, 2022during market hours | – | – | – | Release |
| Q1 FY2022ended Mar 31, 2022 | May 12, 2022during market hours | – | – | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 29, 2022before the open | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
COSCIENS Biopharma has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When COSCIENS Biopharma puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases COSCIENS Biopharma filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
See a number that looks wrong?